Amplify Weight Loss Drug & Treatment ETF (THNR) Open Interest History

Open interest tracks the total number of outstanding options contracts. Rising OI alongside price moves can indicate growing commitment to the trend; declining OI suggests positions are being closed.

Amplify Weight Loss Drug & Treatment ETF (THNR) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $3.4M, listed on AMEX, carrying a beta of 0.38 to the broader market. The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. public since 2024-05-21.

Open interest history tracks how outstanding options contracts change over time. No recent options activity for THNR as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how open interest is reported and how to read the data →